| Transdermal therapeutic systems with crystallization inhibitors R Lipp, J Riedl, J Tack US Patent 5,676,968, 1997 | 140 | 1997 |
| Transdermal Delivery of Highly Lipophilic Drugs: In Vitro Fluxes of Antiestrogens, Permeation Enhancers, and Solvents from Liquid Formulations AP Funke, R Schiller, HW Motzkus, C Günther, RH Müller, R Lipp Pharmaceutical research 19, 661-668, 2002 | 139 | 2002 |
| Novel poloxamer-based nanoemulsions to enhance the intestinal absorption of active compounds C Brüsewitz, A Schendler, A Funke, T Wagner, R Lipp International journal of pharmaceutics 329 (1-2), 173-181, 2007 | 126 | 2007 |
| Transdermal therapeutic systems that contain sex steroids and dimethyl isosorbide R Lipp, C Gunther, J Riedl, U Tauber US Patent 5,904,931, 1999 | 118 | 1999 |
| Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug H Kranz, C Guthmann, T Wagner, R Lipp, J Reinhard European journal of pharmaceutical sciences 26 (1), 47-53, 2005 | 117 | 2005 |
| Drospirenone for hormone replacement therapy W Heil, J Hilmann, R Lipp, R Schuermann US Patent App. 09/757,688, 2002 | 109 | 2002 |
| Synthesis, X-Ray Crystallography, and Pharmacokinetics of Novel Azomethine Prodrugs of (R)-. Alpha.-Methylhistamine: Highly Potent and Selective Histamine H3 Receptor Agonists M Krause, A Rouleau, H Stark, P Luger, R Lipp, M Garbarg, JC Schwartz, ... Journal of medicinal chemistry 38 (20), 4070-4079, 1995 | 76 | 1995 |
| Drospirenone for hormone replacement therapy W Heil, J Hilmann, R Lipp, R Schuermann US Patent App. 10/359,062, 2004 | 75 | 2004 |
| Stabilised supersaturated solids of lipophilic drugs A Funke, T Wagner, R Lipp US Patent 8,715,735, 2014 | 67 | 2014 |
| Agent for transdermal administration that contains gestodene esters R Lipp, H Laurent, C Gunther, J Riedl, P Esperling, U Tauber US Patent 5,858,394, 1999 | 67 | 1999 |
| Selection and use of crystallization inhibitors for matrix-type transdermal drug-delivery systems containing sex steroids R Lipp Journal of pharmacy and pharmacology 50 (12), 1343-1349, 1998 | 67 | 1998 |
| Drospirenone for hormone replacement therapy W Heil, J Hilmann, R Lipp, R Schuermann US Patent App. 10/359,085, 2003 | 64 | 2003 |
| Transdermal therapeutic systems R Lipp, C Gunther US Patent App. 09/214,601, 2001 | 59 | 2001 |
| Pharmaceutical composition for use as a contraceptive J Hilman, W Heil, R Lipp, R Heithecker, M Huempel, JW Tack US Patent 6,787,531, 2004 | 55 | 2004 |
| Transdermal system that contains a new highly potent gestagen R Lipp, C Gunther US Patent App. 10/022,834, 2003 | 54 | 2003 |
| Synthesis, absolute configuration, stereoselectivity, and receptor selectivity of (. alpha. R,. beta. S)-. alpha.,. beta.-dimethylhistamine. A novel highly potent histamine H3 … R Lipp, JM Arrang, M Garbarg, P Luger, JC Schwartz, W Schunack Journal of medicinal chemistry 35 (23), 4434-4441, 1992 | 42 | 1992 |
| Pharmacochemistry of H3-receptors R Lipp, H Stark, W Schunack 00/00, 57-72, 1992 | 41 | 1992 |
| In-vitro release and transdermal fluxes of a highly lipophilic drug and of enhancers from matrix TDS AP Funke, C Günther, RH Müller, R Lipp Journal of controlled release 82 (1), 63-70, 2002 | 39 | 2002 |
| Pharmaceutical compositions and methods for stimulating H3 histamine receptors JM Arrang, M Garbarg, W Schunack, JC Schwartz, RO Lipp US Patent 4,767,778, 1988 | 33 | 1988 |
| Use of X-ray crystallography for the characterization of single crystals grown in steroid containing transdermal drug delivery systems R Lipp, A Müller-Fahrnow European journal of pharmaceutics and biopharmaceutics 47 (2), 133-138, 1999 | 30 | 1999 |
Holger StarkHeinrich Heine University Duesseldorf/Germany在 hhu.de 的电子邮件经过验证
